A dult bone marrow (BM)-derived cells, including hematopoietic and mesenchymal stem cells (MSC), are mobilized and recruited to the heart in response to myocardial injury. 1 Indeed, several clinical studies suggest that injection of BM-derived stem cells including MSCs could have therapeutic benefits in the treatment of ischemic heart diseases. [2] [3] [4] [5] [6] [7] However, the precise signaling mechanisms that govern the function of BM-derived cells and MSCs are not known.
Clinical Perspective on p 876
Notch receptors are important regulators of embryonic development and cardiovascular homeostasis. 8 -11 Through local cellcell interactions, they specify cell fate and tissue patterning and are important mediators of stem cell self-renewal, expansion, survival, and differentiation. [12] [13] [14] In mammals, 4 Notch receptors (Notch1 through Notch4) and 5 structurally similar Notch ligands (Delta-like1, Delta-like3, Delta-like4, Jagged1, and Jag-ged2) have been identified. 8, 15 Both Notch1 and Jagged-1 have been shown to be critical for vasculogenesis and blood flow recovery in ischemic limbs. 16, 17 In the heart, Notch1 regulates the fate of cardiac progenitor cells, stimulates proliferation of immature cardiomyocytes, and limits the extent of cardiomyocytes hypertrophic response. 10,18 -20 Selective overexpression of Notch1 intracellular domain (NICD) in cardiomyocytes leads to multiple cardiac defects whereas cardiac-specific silencing of all 4 mammalian Notch receptors in early cardiogenesis perturbs cardiac morphogenesis. 21 Indeed, several recent studies suggest that Notch signaling may protect the heart after myocardial infarction. 18, 21, 22 However, it is not known whether Notch signaling could contribute to cardiac repair by regulating the function of postnatal cardiomyocytes or BM-derived cells.
Isolation and Culture of BM-Derived MSC
Isolation and purification of MSC were performed as described (Materials and Methods, online-only Data Supplement). 27 The cell surface markers that were used to identify MSC were positive staining for CD105 and Sca-1 and negative staining for CD45, CD34, and c-Kit. 28 In some experiments, MSC at passage 4 were used for intramyocardial injection after LAD ligation. For NICDadenoviral infection studies, MSC were infected with Ad.GFP or Ad.NICD at a multiplicity of infection of 100 for 24 hours. 11
MSC Migration and Coculture Assay
Neonatal cardiomyocytes were isolated as described. 29 MSC migration assay was performed as described (see Materials and Methods, online-only Data Supplement). 30 
Real-Time Polymerase Chain Reaction
The primers that were used were as follows: Hey1 forward: 5Ј-GCGCGGACGAGAATGGAAA-3Ј, Hey1 reverse: 5Ј-TCAG GTGATCCACAGTCATCTG-3Ј; HeyL forward: 5Ј-CAGCCCTT CGCAGATGCAA-3Ј, HeyL reverse: 5Ј-CCAATCGTCGCAATTCAG-AAAG-3Ј; CSF3R forward: 5Ј-CTGATCTTCTTGCTACTCCCCA-3Ј, CSF3R reverse: 5Ј-GGTGTAGTTCAA GTGAGGCAG-3Ј; CXCR4 forward: 5Ј-GAAGTGGGGTCTGGAGACTAT-3Ј, CXCR4 reverse: 5Ј-TTGCCGACTATGCCAGTCA AG-3Ј.
Statistical Analysis
Results are expressed as mean with 95% confidence intervals (CIs). Some in vitro experimental results are expressed as meanϮSD. The data among groups were compared with 1-way ANOVA. The mortality was compared with Pearson 2 analysis (SPSS, version 13, SPSS Inc, Chicago, IL). A P value Ͻ0.05 was taken to be statistically significant.
Results

Protective Role of Notch1 After Myocardial Injury
Notch1 and NICD expression were upregulated in the heart and BM after LAD ligation ( Figure 1A ). Because homozygous deletion of Notch1 leads to embryonic lethality, [31] [32] [33] we used global N1 Ϯ mice 31 ( Figure 1B , top panels), which are viable and phenotypically normal compared with wild-type (WT) littermate mice (data not shown). After LAD ligation, there were no difference in mortality between N1 Ϯ mice and WT littermate mice (14% versus 0%; Pϭ0.142; nϭ14 each). Seven days after LAD ligation, myocardial infarct size was larger in N1 Ϯ mice compared with WT mice (34.9%, 95% CI, 27.8 to 42.0, versus 25.4%, 95% CI, 19.1 to 31.7; Pϭ0.048; Figure 1B , bottom panels). Echocardiography showed decreased fractional shortening (FS) and ejection fraction (EF) in N1 Ϯ mice compared with WT mice (Table, see 
There was less vascularization in the infarct border zone of N1 Ϯ mice than that in WT mice. Relative number of isolectin B4 -positive cells in N1 Ϯ mice was 53.5% (95% CI, 45.0 to 61.9) compared with WT mice (100%; Pϭ0.045; Figure 1C , top panel). This corresponded to a decreased number of CD31ϩ vessels in N1 Ϯ mice compared with WT mice (933 vessel number/mm 2 [95% CI, 740 to 1127] versus 1336 vessel number/mm 2 [95% CI, 1082 to 1589]; Pϭ0.017; Figure 1C , middle panel). The number of surviving cardiomyocytes as determined by ␣-actinin-2 staining was greatly reduced in N1 Ϯ mice compared with WT mice ( Figure 1C , bottom panels). Similar to what was observed at 7 days after LAD ligation, myocardial infarct size was larger in N1 Ϯ mice compared with WT mice at 28 days after LAD ligation ( Figure 1D ). Echocardiography showed enlarged cardiac dimensions in N1 Ϯ -mice compared with WT mice. This correlated with decreased cardiac function in N1 Ϯ mice compared with WT mice (Table) .
Notch1 in Postnatal Cardiomyocytes Does Not Contribute to Cardiac Repair
Because ␣MHC expression peaks after birth and is maintained at high levels during the postnatal period in both atrial and ventricular cardiomyocytes, 24 cardiac-specific Notch1 deletion in C-N1 -/mice occurs predominantly in postnatal cardiomyocytes ( Figure 2A ). C-N1 -/mice develop normally and have normal cardiac dimensions and function compared with control mice (ie, ␣MHC-Cre and Notch1 flox/flox ). After LAD ligation, C-N1 -/mice and control mice showed a similar mortality rate (20% in C-N1 -/mice versus 13% in control mice; Pϭ0.67; nϭ10 in C-N1 -/mice and 8 in control mice), infarct size (44.3% [95% CI, 39.2 to 49.3] versus 40.8% [95% CI, 21.9 to 59.6]; Pϭ0.706; Figure 2B ) and cardiac dimensions and function (Table) .
Compared with control mice (␣MHC-Cre) without LAD ligation (sham), Notch2 and Notch3 expression were slightly higher in C-N1 -/mice. After LAD ligation, the expression of all Notch receptors was increased in control mice. In C-N1 -/mice, the expression of Notch2 and Notch3 was further augmented compared with control mice ( Figure 2C ), suggesting that Notch2 and Notch3 may compensate for the loss of Notch1 in cardiomyocytes.
Notch1 in BM-Derived Cells Contributes to Cardiac Repair
The N1 Ϯ BMT (N1 Ϯ 3 WT) mice exhibited a mortality rate that was similar to that of WT BMT (WT3 WT) mice after LAD ligation (23% versus 14%; Pϭ0.56; nϭ13 in N1 Ϯ BMT mice and 14 in WT BMT mice). However, after LAD ligation, infarct size was larger in N1 Ϯ BMT mice compared with WT BMT mice (49.4% [95% CI, 44.7 to 54.1] versus 36.4% [95% CI, 32.1 to 40.8], PϽ0.001; Figure 2D ). This corresponded to enlarged cardiac dimensions and reduced cardiac function in N1 Ϯ BMT mice compared with WT BMT mice (Table) .
To determine whether Notch1 in non-BM-derived cells could also contribute to cardiac repair, we transplanted BM from WT mice into WT and N1 Ϯ recipient mice. Again, survival rates after BMT and LAD ligation were not different, and there were no differences in physiological data, cardiac dimensions, and heart function before LAD ligation. Surpris-ingly, there were no differences in infarct size ( Figure 2E ), cardiac dimensions, and heart function between WT3 WT BMT and WT3 N1 Ϯ -BMT mice after LAD ligation (Table) , suggesting that Notch1 in non-BM-derived cells does not contribute to cardiac repair after myocardial injury. There were more Ki-67-positive cells in the infarct border zone in WT BMT mice than in N1 Ϯ -BMT mice (13.9% [95% CI, 11.2 to 16.5] versus 9.9% [95% CI, 7.9 to 11.9]; Pϭ0.029; Figure 2F ). In contrast, WT3 WT BMT mice showed amounts of Ki-67positive cells that were similar those in WT3 N1 Ϯ -mice (17.1% [95% CI, 12.3 to 21.9] versus 15.8% [95% CI, 12.5 to 19.1]; Pϭ0.639; Figure 2G ).
Notch1 Mediates Vascularization and Recruitment of BM-Derived Cells to the Infarct Border Area
CD31 staining revealed decreased capillary density in the infarct border of N1 Ϯ -BMT mice compared with WT BMT mice (CD31 ϩ vessel number/mm 2 : 1053 [95% CI, 836 to 1270] versus 1500 [95% CI, 1287 to 1713]; Pϭ0.006). This was accompanied by a decrease in the perfusion area in the infarct border area of N1 Ϯ BMT mice compared with WT BMT mice (percentage lumen area of total border zone: 3.1 [95% CI, 1.5 to 4.8] versus 5.5 [95% CI, 3.9 to 7.0]; Pϭ0.049; Figure 3A ).
To determine whether Notch1 regulates the recruitment of BM-derived cells into the injured heart, we transplanted BM taken from GFP-WT mice or littermate-matched GFP-N1 Ϯ mice into recipient WT mice. Blood cell count and differential were not different between GFP-WT BMT mice and GFP-N1 Ϯ BMT mice (data not shown). Transplantation efficacy was similar between GFP-WT BMT mice and GFP-N1 Ϯ BMT mice (88.6% versus 86.9%; Pϭ0.58; nϭ20 each). Three days after LAD ligation, GFP-N1 Ϯ BMT mice showed decreased GFP expression and GFP-positive cells in the infarct border area compared with GFP-WT BMT mice (GFP-positive cell number/mm 2 : 664 [95% CI, 78 to 1251] versus 1395 [95% CI, 1133 to 1658]; Pϭ0.042; Figure 3B ).
The BM-derived NICD-positive cells in the infarct border area were also decreased in GFP-N1 Ϯ BMT mice compared with GFP-WT BMT mice (percentage NICD-positive cells: 12 Figure 3C , left panels). This corresponded to decreased Notch1 and NICD expression in the infarct border area ( Figure 3C , right panel). Using Ki-67 staining, we found decreased proliferation of BM-derived cells in the infarct border zone of GFP-N1 Ϯ BMT mice compared with GFP-WT BMT mice (2.6% [95% CI: 1.9 to 3.3] versus 5.8% [95% CI, 3.4 to 8.3]; Pϭ0.021; Figure 3D ). Seven days after LAD ligation, there were decreased proportions of GFP ϩ smooth muscle actin-positive (SMA ϩ ) cells (4.1% [95% CI, 2.8 to 5.5] versus 6.7% [95% CI, 5.1 to 8.3]; Pϭ0.024) and GFP ϩ isolectin B4-positive (IB4 ϩ ) cells (22.3% [95% CI, 20.0 to 24.5] versus 26.2% [95% CI, 23.3 to 29.1]; Pϭ0.050) relative to the total number of GFP ϩ cells in the infarct border area of GFP-N1 Ϯ BMT mice compared with GFP-WT BMT mice ( Figure 4A and 4B ). More definitive staining of smooth muscle cells and endothelial cells with SM MHC and CD31, respectively, revealed little if any staining (data not shown), suggesting that BM-derived cells were vascular-like rather than definitive vascular cells. However, costaining the IB4 ϩ and SMA ϩ cells for CD68 indicated that most of these transdifferentiated vascular-like cells were not juxtaposed macrophages (data not shown). Furthermore, very few, if any, GFP ϩ cells were found to costain with ␣-actinin-2 or cardiac troponin T in either GFP-N1 Ϯ BMT or GFP-WT BMT mice. Deficiency of Notch1 in BM also leads to increased apoptosis of BM-derived cells in the infarct border zone compared with WT BM (cleaved-Caspase3ϩ cells: 39 Figure 4C ). Although vascular endothelial growth factor (VEGF) expression was increased in both WT BMT and N1 Ϯ BMT mice after LAD ligation, WT BMT mice showed higher VEGF expression than N1 Ϯ BMT mice ( Figure 4D ). These findings suggest that Notch1 in BM-derived cells contributes to vascularization through paracrine effects rather than transdifferentiation into vascular cells.
Table. Cardiac Dimensions and Systolic Function Evaluated by Echocardiography
Notch1 in BM-Derived MSC Mediates Cardiac Repair
To determine which subgroups of BM-derived cells are regulated by Notch1, we costained GFP ϩ cells in the heart with different cell markers at 1 day after LAD ligation. In contrast to CD34ϩ, CD45ϩ, c-kitϩ, CD4ϩ, CD68ϩ, CD14ϩ, and CD11bϩ cells, we found more CD105ϩ and Sca-1ϩ cells in the GFP-WT BMT mice compared with GFP-N1 Ϯ BMT mice ( Figure 5A ). Because MSC express CD105 and Sca-1 and are negative for CD34, CD45, c-kit, and CD4, 28 these findings suggest that Notch1 may increase the recruitment of BM-derived MSC to the injured heart.
To investigate whether Notch1 in MSC directly mediate the cardiac repair process, LAD ligation was performed on C57Bl/6 WT mice followed by intramyocardial injection of 5Ј10 5 GFP-WT or GFP-N1 Ϯ MSC at passage 4. After LAD ligation, infarct size was larger with N1 Ϯ MSC injection compared with WT MSC injection (48.5% [95% CI, 46.0 to 50.9] versus 42.5% [95% CI, 37.9 to 47.1]; Pϭ0.036; nϭ12 each) ( Figure 5B) . Similarly, echocardiography showed greater cardiac dimensions and decreased cardiac function with N1 Ϯ MSC injection compared with WT MSC injection (Table) . Indeed, there was a greater number of MSC in the infarct border zone after injection of WT MSC compared with after injection of N1 Ϯ MSC ( Figure 5C ). Conversely, injection of NICD-adenoviral-infected MSC leads to decreased infarct size and improved heart function compared with GFP-adenoviral-infected MSC (control) (infarct size: 38.9% [95% CI, 34.7 to 43.0] versus 43.8% [95% CI, 41.6 to 46.1]; Pϭ0.05, nϭ12 each; Figure 5D and the Table) . These findings suggest that Notch1 in MSC is a critical mediator of cardiac repair after myocardial ischemia.
Notch1 Regulates MSC Proliferation and Function
When MSC were isolated and cultured, there was no observable difference in cell number between WT and N1 Ϯ MSC in primary and passage 1 cultures. However, after 2 to 3 passages, N1 Ϯ MSC have less proliferative capacity compared with WT MSC (Figure 6A ). At cellular passage 2, MSC from N1 Ϯ mice BM exhibited decreased Ki-67 staining compared with MSC from WT mice (percentage Ki-67-positive cells: 10.5Ϯ5.6 versus 33.6Ϯ15.6; Pϭ 0.014; Figure 6B , left panels). This corresponded with decreased protein synthesis (ie, [ 3 H]-leucine incorporation) in N1 Ϯ MSC compared with WT MSC (110.2Ϯ77.9 cpm versus 262.7Ϯ137.9 cpm; Pϭ0.040; Figure 6B , second right panel). Furthermore, N1 Ϯ MSC showed impaired migratory ability compared with WT MSC (percentage migration ratio: 10.7Ϯ6.5 versus 17.9Ϯ2.8; Pϭ0.050; Figure 6B , right panel). The expression of Notch1 target genes Hey1 and HeyL were reduced in N1 Ϯ MSC compared with WT MSC. Overexpression of NICD in N1 Ϯ MSC with NICD-adenoviral infection increased their expression ( Figure 6C, left panels) . The expression of other Notch downstream targets such as Hes3, Hes5, and Hes7 were too low to be detected, and the expression of Hes1, Hes2, and Hey2 were not altered (data not shown). Furthermore, the expression of colonystimulating factor 3 receptor (CSF3R) and CXC chemokine receptor 4 (CXCR4) was also reduced in N1 Ϯ MSC compared with WT MSC, which was reversed by NICDadenoviral infection ( Figure 6C, right panels) . However, the expression of their ligands, granulocyte-colony stimulating factor and stromal cell-derived factor-1 were similar between WT and N1 Ϯ MSC (data not shown).
Discussion
We have shown that Notch1 in BM-derived cells are involved in cardiac repair after myocardial infarction. The protective mechanism may be due, in part, to Notch1-mediated neovascularization in the infarcted hearts. Indeed, isolectin B4 and CD31 staining for microvessel formation in the infarct border zone, as well as VEGF expression, was greatly reduced in N1 Ϯ mice. These findings are consistent with previous studies showing potential cross-talk between Notch and other vascular signaling pathways involving VEGF, plateletderived growth factor, Wnt, hedgehog, and bone morphogenic protein in regulating arteriogenesis. 9,34 -38 These results are also consistent with a recent hindlimb ischemia study showing that inactivation of Jagged-1-mediated Notch signaling leads to inhibition of postnatal vasculogenesis in hindlimb ischemia via impairment of proliferation, survival, and mobilization of BM-derived EPCs. 17 Interestingly, the loss of Notch1 in postnatal cardiomyocyte did not affect the severity of myocardial injury, suggesting that other Notch receptors may compensate for the loss of function of cardiomyocyte Notch1. Indeed, increased expression of other Notch receptors such as Notch2 and Notch3 was observed in cardiomyocyte-specific Notch1 knockout mice. This increase in Notch expression after infarction may be partly attributed to Notch expression in recruited BM-derived cells. Furthermore, we could not exclude the contributions of Notch1 signaling in immature cardiomyocytes and/or CPCs. CPCs do not express ␣MHC and thus are not subjected to Cre-mediated excision with ␣MHC-Cre. Indeed, transplantation of a CPC sheet could improve cardiac function through para- crine mechanisms mediated via the soluble vascular adhesion molecule-1/very late antigen-4 signaling pathway. 39 The importance of Notch signaling in MSC is underscored by the finding that injection of infarcted hearts with MSC overexpressing NICD decreases infarct size and improves heart function in a fashion similar to what was observed previously. 22 Conversely, injection of Notch1-deficient MSC into the infarcted heart leads to increased infarct size and worsening of cardiac function. Decreased expression of Hey1 and HeyL in Notch1-deficient MSC suggests that Hey1 and HeyL are potential targets of Notch1 signaling in BM-derived MSC. Furthermore, downregulation of CSF3R and CXCR4 expression in N1 Ϯ MSC suggests that Notch1 may mediate the mobilization and migration of BM cells through CSF3R and CXCR4 signaling pathways. Indeed, granulocyte-colony stimulating factor/CSF3R and stromal cell-derived factor-1/ CXCR4 signaling contribute importantly to the recruitment of BM-derived cells to the injured tissues. 2,40 -45 Interestingly, Notch1 upregulates CXCR4 46 and mediates the response of BM-derived cells to GCSF by its intracellular cdc10 repeat domain. 47 Taken together, these findings suggest a critical role of Notch signaling in BM-derived MSC in cardiac repair.
We found that BM-derived cells accumulation was greatly reduced in the infarct border zone after myocardial infarction in N1 Ϯ BMT mice compared with WT BMT mice. Once recruited, BM-derived cells could secrete growth factors and cytokines that could promote neovascularization and prevent cardiomyocyte apoptosis in the infarct border zone. 2, 39, 40, 48 This paracrine mechanism may be especially important because most of the cells that are recruited to the infarct border zone are leukocytes. Although the absolute number of inflammatory cells in the infarcted heart was greater in GFP-WT BMT mice compared with N1 Ϯ -WT BMT mice, the proportion of BM-derived CD68ϩ, Cd14ϩ, or CD11bϩ cells relative to the total number of GFP ϩ cells in the infarct border zone after LAD ligation was not different between GFP-WT BMT and N1 Ϯ -WT BMT mice. Indeed, the only BM-derived cell type whose relative proportion was found to be different between GFP-WT BMT and N1 Ϯ -WT BMT mice after myocardial infarction was MSC, suggesting that MSC are the key cell population in Notch1-mediated protection. Nevertheless, the contributory role of Notch1 in BM-derived inflammatory cells such as macrophages in cardiac repair may be very important and needs more detail investigation.
Both experimental and clinical studies have demonstrated that BM-derived cells contribute to cardiac repair after myocardial infarction. [1] [2] [3] [4] [5] [6] [7] However, there are some disparities between these cell-based therapies. For example, pharmaco- logical mobilization of BM-derived cells improved heart function in animal studies 2,40 whereas it does not affect systolic function in human clinical trials. 49, 50 In addition, contradictory findings between direct infusion of BMaspirated cells versus pharmacological mobilization of BMderived stem cells are observed in clinical trials. It is possible that Notch1 signaling promotes this selective mobilization of MSC from BM-derived stem cells. Indeed, a substudy of the Stem Cells in Myocardial Infarction (STEMMI) trial suggests the importance of MSC mobilization for heart function recovery. 50 Our findings are in agreement on the importance of MSC but further suggest that modulation of Notch1 signaling in MSC may improve MSC function in terms of mobilization and/or recruitment to the injured heart.
Limitations
There are several limitations to this study. As mentioned, IB4 and SMA are not definitive markers for mature endothelial cells and SMC, respectively. Therefore, we performed additional studies with double staining of GFP with CD31 or SM-MHC to evaluate whether BM-derived cells could transdifferentiate into functional mature endothelial cells and SMC. Unfortunately, only a few GFP ϩ cells were found to costain with CD31 in GFP-WT BMT mice, and very few, if any, in GFP-N1 Ϯ BMT mice. Furthermore, few if any GFP ϩ cells were found to costain with SM-MHC in either GFP-N1 Ϯ BMT or GFP-WT BMT mice (data not shown). Our results, therefore, suggest that BM-derived cells do not appreciably transdifferentiate into vascular cells in the infarcted heart. 51 Finally, we used immunohistochemistry to semiquantify the subsets of BM-derived cells in the infarcted heart. Perhaps a more accurate method for quantifyng subsets of the cells in the infarcted heart is with the use of flow cytometry. 52
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